Active Filter(s):
Details:
Vaccine candidate, which combines a nanoparticle developed by a Duke-led research team with IDRI’s novel formulation of 3M’s “3M-052” compound Produced more “broadly neutralizing antibodies” against several strains of coronavirus, including bat coronaviruses.
Lead Product(s): 3M-052,Potassium Alum
Therapeutic Area: Infections and Infectious Diseases Product Name: 3M-052
Highest Development Status: Preclinical Product Type: Vaccine
Partner/Sponsor/Collaborator: IDRI
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration May 03, 2021